BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 16961805)

  • 1. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic options after failed Helicobacter pylori eradication therapy.
    van der Hulst RW; Weel JF; van der Ende A; ten Kate FJ; Dankert J; Tytgat GN
    Am J Gastroenterol; 1996 Nov; 91(11):2333-7. PubMed ID: 8931413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy].
    Iwasaki A
    Nihon Rinsho; 1999 Jan; 57(1):127-33. PubMed ID: 10036949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer.
    Lazzaroni M; Bargiggia S; Bianchi Porro G
    Am J Gastroenterol; 1997 Apr; 92(4):649-52. PubMed ID: 9128316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lansoprazole on Helicobacter pylori.
    Lamouliatte H
    Clin Ther; 1993; 15 Suppl B():32-6. PubMed ID: 8205593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori.
    Taylor JL; Zagari M; Murphy K; Freston JW
    Arch Intern Med; 1997 Jan; 157(1):87-97. PubMed ID: 8996045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Helicobacter pylori eradication: modified triple therapy with lansoprazole].
    Müller P; Simon B
    Fortschr Med; 1996 Dec; 114(35-36):497-9. PubMed ID: 9119351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G; Layer P; Goebell H
    Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term low-dose triple therapy with lansoprazole plus amoxycillin and clarithromycin for Helicobacter pylori eradication.
    Tursi A; Cammarota G; Papa A; Montalto M; Fedeli G; Gasbarrini G
    Am J Gastroenterol; 1996 Aug; 91(8):1668-70. PubMed ID: 8759696
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication.
    Kawano S; Murakami M; Saita H; Tsuji S
    J Gastroenterol; 1996 Nov; 31 Suppl 9():41-3. PubMed ID: 8959517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proton-pump inhibitors versus H2-receptor antagonists in triple therapy for Helicobacter pylori eradication].
    Kanayama S
    Nihon Rinsho; 1999 Jan; 57(1):153-6. PubMed ID: 10036954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [History of the treatment of Helicobacter pylori and clinical efficacy].
    Yamamoto I; Fukuda Y; Shimoyama T
    Nihon Rinsho; 1999 Jan; 57(1):32-42. PubMed ID: 10036933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving therapy for Helicobacter pylori infection: efficacy and economic impact in the treatment of patients with duodenal ulcer disease.
    Cutler AF; Vakil N
    Am J Manag Care; 1997 Oct; 3(10):1528-34. PubMed ID: 10178459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori.
    Smoot DT; Hinds T; Ashktorab H; Jagtap J; Kim KS; Scott VF
    Am J Gastroenterol; 1999 Apr; 94(4):955-8. PubMed ID: 10201463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
    Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
    Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of Helicobacter pylori by a 1-week course of famotidine, amoxicillin and clarithromycin.
    Gschwantler M; Dragosics B; Wurzer H; Brandstätter G; Weiss W
    Eur J Gastroenterol Hepatol; 1998 Jul; 10(7):579-82. PubMed ID: 9855082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological therapy of Helicobacter pylori infection.
    Hoffman JS
    Semin Gastrointest Dis; 1997 Jul; 8(3):156-63. PubMed ID: 9232728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of Helicobacter pylori followed by reinfection.
    Tonokatsu Y; Fukuda Y; Tsujiai T; Tamura K; Shimoyama T
    J Gastroenterol; 1996 Nov; 31 Suppl 9():75-6. PubMed ID: 8959526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutic approaches to the management of Helicobacter pylori infection.
    Montague S; O'Morain CA
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S334-8. PubMed ID: 10077769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in Helicobacter pylori eradication therapy.
    Pounder RE
    Scand J Gastroenterol Suppl; 1997; 223():43-5. PubMed ID: 9200305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.